These findings are consistent with the study by Liu et al., which highlighted that among the HCV-associated HCC patients, PIVKA-II alone showed the highest individual diagnostic accuracy, and its combination with AFP yielded the best overall performance [26]. The gene discussed is AFP; the disease is hepatocellular carcinoma.